How will Malaysia ensure rare disease inclusivity in Asean?

Question

Accepted Answer

Malaysia to Champion Rare Disease Inclusivity Across Asean

Malaysia is committed to fostering inclusivity for rare diseases within Asean, aiming to elevate the issue as a regional priority during its chairmanship of the Asean Health Ministers’ Meeting (AHMM) in 2026. This initiative will be guided by a people-centred strategy, emphasizing solidarity and practical harmony among member states, with a particular focus on strengthening regional cooperation. The overarching goal is to ensure that no individual affected by a rare disease is overlooked, thereby promoting equitable access to care and support across the region.
People-Centred Strategy and Regional Cooperation

As the host of the AHMM 2026, Malaysia intends to champion a people-centred approach to rare diseases. This strategy underscores the importance of regional cooperation to address the unique challenges faced by patients and healthcare systems across Asean. The commitment to practical harmony suggests an effort to align policies and practices, fostering a more cohesive and effective regional response to rare diseases.
Principles of Inclusivity, Solidarity, and Sustainability

The elevation of rare diseases within Asean will be underpinned by three core principles: inclusivity, solidarity, and sustainability. Inclusivity, defined as ensuring no one is left behind, is central to Malaysia's vision. Solidarity signifies the necessity of strong and ongoing collaboration among Asean nations, while sustainability aims to secure long-term funding and treatment accessibility. These principles were previously highlighted at the South-east Asia Rare Disease Policy Forum, indicating a consistent focus on these foundational elements.
Key Priorities for Rare Disease Management

Malaysia's priorities for enhancing rare disease management at the Asean level include the reinforcement of capacity-building efforts, the establishment of centres of excellence, and the promotion of research collaboration and clinical trials. Furthermore, strengthening governance structures and empowering patients are identified as crucial components. The development of a national rare disease registry and sustainable treatment financing mechanisms are also highlighted as key areas for focus, alongside fostering cross-border collaboration to avoid fragmented approaches.

Reading history

Hide →

This history is cleared when the page is closed.

How will Malaysia ensure rare disease inclusivity in Asean?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends